Linda E. Lévesque

Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes

Linda E. Lévesque, J. A Hanley, Abbas Kezouh et al. · BMJ · 2010 · 1.2K citations

Public Health, Biostatistics, Pharmacotherapy +12

Reduction of Morbidity and Mortality by Statins, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin Receptor Blockers in Patients With Chronic Obstructive Pulmonary Disease

G.B. John Mancini, Mahyar Etminan, Bin Zhang et al. · Journal of the American College of Cardiology · 2006 · 401 citations

Medicine, Pharmacology, Pharmacotherapy +12

Thiazolidinediones and Cardiovascular Outcomes in Older Patients With Diabetes

Lorraine L. Lipscombe, Tara Gomes, Linda E. Lévesque et al. · JAMA · 2007 · 347 citations

Pharmacy, Cardiology, Pharmacotherapy +17

Association of Selective and Conventional Nonsteroidal Antiinflammatory Drugs with Acute Renal Failure: A Population-based, Nested Case-Control Analysis

Verena Schneider, Linda E. Lévesque, Bin Zhang et al. · American Journal of Epidemiology · 2006 · 268 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

The Risk for Myocardial Infarction with Cyclooxygenase-2 Inhibitors: A Population Study of Elderly Adults

Linda E. Lévesque, James M. Brophy, Bin Zhang · Annals of Internal Medicine · 2005 · 249 citations

Pharmacy, Pharmacology, Pharmacotherapy +17